共 50 条
- [22] PROPERDIN AND CLINICAL DISEASE ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) CLINICAL RESEARCH, 1975, 23 (03): : A412 - A412
- [23] CLINICAL MEASURES OF SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) DISEASE-ACTIVITY ARE MORE RESPONSIVE THAN LABORATORY MEASURES ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S195 - S195
- [24] ANTIBODIES TO SM IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - CORRELATION WITH DISEASE-ACTIVITY ARTHRITIS AND RHEUMATISM, 1980, 23 (06): : 652 - 652
- [25] SERUM THROMBOMODULIN - A NOVEL MARKER OF DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS ARTHRITIS AND RHEUMATISM, 1994, 37 (04): : 572 - 577
- [27] CORRELATIONS OF GLOBAL MEASURES OF DISEASE-ACTIVITY AND TREATMENT IN SYSTEMIC LUPUS-ERYTHEMATOSUS ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S365 - S365
- [29] HEALTH-STATUS, DISEASE-ACTIVITY AND SEVERITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S185 - S185
- [30] SURFACE EXPRESSION OF CR3 ON NEUTROPHILS (PMN) AS A MARKER OF DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) CLINICAL RESEARCH, 1986, 34 (02): : A614 - A614